# A Study of BGM0504 Tablets in Healthy Chinese Subjects

> **NCT07566572** · PHASE1 · RECRUITING · sponsor: **BrightGene Bio-Medical Technology Co., Ltd.** · enrollment: 144 (estimated)

## Conditions studied

- Chinese Healthy Volunteers

## Interventions

- **DRUG:** BGM0504 tablets

## Key facts

- **NCT ID:** NCT07566572
- **Lead sponsor:** BrightGene Bio-Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-26
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07566572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07566572, "A Study of BGM0504 Tablets in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07566572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*